Rankings
▼
Calendar
ELVN Q1 2019 Earnings — Enliven Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ELVN
Enliven Therapeutics, Inc.
$2B
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.97
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$95,000
← FY 2019
All Quarters
Q2 2019 →